Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Final Results

3rd Jun 2025 07:00

RNS Number : 0869L
Engage XR Holdings PLC
03 June 2025
 

 3 June 2025

 

ENGAGE XR Holdings Plc

("ENGAGE XR", the "Company", or the "Group")

 

Final Results

 

ENGAGE XR Holdings Plc (AIM: EXR), a leading provider of immersive communications technology, announces its audited results for the year ended 31 December 2024.

 

Financial Highlights:

· Total revenue of €3.4 million (2023: €3.7 million), reflecting an 8% decline due to delayed contract closures (expected in 2025) and reduced one-off enterprise activity.

· Education revenue grew to €1.3 million (2023: €1.1 million), driven by strong renewals and expansion from key partners including OptimaED (USA) and InspiredED (UK).

· Gross margin of 86% (2023: 90%).

· EBITDA loss narrowed slightly to €3.9 million (2023: €4.0 million), reflecting disciplined cost control.

· Cash position of €3.6 million at 31 December 2024 (2023: €7.9 million), with no debt.

 

Operational Highlights:

· Continued pivot to education and training: Education and corporate training now represent over 50% of revenue YTD 2025, up from 38% in FY24.

· Partnership with OptimaED has shown significant growth, increasing its licenses sixfold from 500 at the start of 2023 to over 3,000 licenses currently, with plans to double again this year.

· Delivered the Group's largest ever contract with major client in Middle East in partnership with PwC. Renewed contracts with Bank of America, KPMG, and PWC.

· "School of AI" initiative now live enabling immersive, AI-powered learning experiences. Thousands of students engage daily.

 

Current trading and Outlook:

· The first five months of the current financial year has seen the Company make good progress in broadening its opportunities, but the Company is still being impacted by delays in the pipeline converting into signed contracts.

· Operating cost base reduced significantly in Q2 2025 with monthly run-rate of costs now approx.€0.2 million.

· Expect progress in the sales pipeline throughout 2025 and 2026 as Group works closely with Meta, Lenovo and a host of global resellers who already have a large potential client base to sell to.

 

David Whelan, CEO of ENGAGE XR, commented: "2024 was a year of transition and strategic change. While headline revenue declined, our pivot to education and training is delivering tangible results. With strong partnerships, a growing reseller network, and a leaner cost base, we are well positioned to scale recurring revenue and deliver long-term value."

 

For further information, please contact:

 

ENGAGE XR Holdings Plc

David Whelan, CEO

Séamus Larrissey, CFO

Sandra Whelan, COO

 

Tel: +353 87 665 6708

[email protected]

Cavendish Capital Markets Limited

(Nominated Adviser & Broker)

 

Marc Milmo/ Seamus Fricker (Corporate finance)

Sunila de Silva (ECM)

 

Tel: +44 (0) 20 7220 0500

SEC Newgate (Financial Communications)

Robin Tozer

Tel: +44 (0)7540 106366

[email protected]

 

 

About ENGAGE XR

ENGAGE XR Holdings plc (AIM: EXR) has developed ENGAGE, an immersive training, education and collaboration platform, offering cutting-edge VR/AR tools and environments that elevate employee training and student outcomes. Trusted by enterprise and educational clients worldwide, ENGAGE leverages the transformative power of spatial computing to revolutionize onboarding, sales meetings, product demos and a host of other vital business operations.

 

For further information, please visit: https://engagevr.io/

 

 

CHAIRMAN'S STATEMENT

 

This has been a year of significant challenge and transformation for Engage XR as we navigated macroeconomic volatility and adapted to changes in enterprise demand.

 

2024 Performance and Strategic Progress

Revenue declined by 8% to €3.4 million, with 2024 seeing continued reduction in enterprise spending and renewals and reduced one-off event activity. Furthermore, a significant contract was also expected to be finalised pre year end in the Middle East which would have led to the Group's revenue target being comfortably achieved but unfortunately this has been delayed into H2 FY25. While this delay resulted in the Group's headline revenue being behind market expectations, the Group's EBITDA and Cash are broadly in-line for FY24. While enterprise revenue declined due in part to post-pandemic workplace shifts as more people returned to the office, we believe churn has stabilised. However, the revenue decline masks a pivotal shift in the business mix. Revenue from the education and corporate training sectors rose 60%, driven by partnerships with institutions such as PWC in the Middle East and leading private education organisations in the US and UK. This aligns with our strategic pivot toward sectors offering sustainable, recurring revenues and measurable ROI. Our presence in the Middle East and expanding AI-led education offerings will drive revenue in the future.

 

Gross margin held firm at 86% (2023: 90%), and cost discipline reduced our EBITDA loss slightly to €3.9 million (2023: €4.0m). We closed the year with €3.6 million in cash and remain debt-free, giving us the flexibility to invest in future growth.

 

Outlook and Board Confidence

During the first five months of the current financial year, the Company has made solid progress in expanding its pipeline of opportunities in the Middle East and in North America. However, it continues to be impacted by delays in converting pipeline prospects into signed contracts. As a result, revenues in the period were below the corresponding period in FY24. In response, the Board has implemented measures to better align the Company's cost base with its current revenue profile. These measures will ensure the Company has the cash to ensure it can capitalise on the opportunities in progress.

 

We continue to develop opportunities through our strategic partnerships with Lenovo, Meta and other key partners in the Education and Corporate Training space, with contributions expected by year-end. The launch of our School of AI initiative and forthcoming AI-based enterprise training tools reinforces our position at the intersection of immersive technology and scalable learning. The Board is confident that this focus will drive long-term, recurring revenue growth and value creation.

 

Looking forwards, the Board continues to see significant growth opportunities for the Group through working with partners in the Middle East throughout the remainder of 2025 and beyond in both education and training verticals. The Group's strong pipeline is evidence of the progress being made with partners in the Middle East and in the USA. This pipeline gives the Board the continued confidence in the market opportunity for the Group and delivering results that benefit not just ENGAGE XR but also its partners and stakeholders. The key focus for the Board is to capitalise on the strength of the pipeline by converting more of its opportunities into contracts with the Board remaining confident in its strategic objective to become cash flow breakeven which it now expects to occur in FY26.

 

Board Governance and Acknowledgments

We were pleased to welcome Marc Metis to the Board as a Non-Executive Director in May 2024. As permitted by the shareholder agreement, Marc joined the Board as the representative of HTC which owns 11.96% of the total issued share capital of ENGAGE XR. Marc replaced Praveen Gupta who retired from HTC. Marc brings extensive global experience in immersive tech and strategic growth, including leadership roles at HTC.

 

I joined the Board as the Group's new non-Executive Chairman on 1 July 2024, replacing Richard Cooper, who had led the Board since the Group's IPO. Richard remains on the board as Senior Independent Director, Chair of the Audit Committee, and on the Remuneration Committee. Non-executive director, Kenny Jacobs, replaced Richard as Chair of the Remuneration Committee.

 

I thank my fellow Directors for their guidance and the management team for their resilience and execution. To our shareholders, thank you for your continued confidence and support as we advance our vision for Engage XR.

 

Karthik Manimozhi

Non-Executive Chairman

3 June 2025

CHIEF EXECUTIVE'S REVIEW

 

Overview

2024 has been a challenging year. While revenue declined, our revenue mix shows that our one-off project-based enterprise revenue streams were being replaced by recurring educational sector license-based revenue streams. We have signed up with several global resellers in partnership with Meta and Lenovo to go head-to-head with the market leaders in the immersive hardware and software education space.

 

ENGAGE was originally founded with a focus on the education sector and operated under the name Immersive VR Education. The company rebranded during the COVID lockdowns to better reflect the growing split between enterprise and education revenue, as we saw increased demand from corporations supporting remote teams. However, towards the end of 2023 and into the first half of 2024, I made the strategic decision to refocus the company on education and training services. This was driven by consistently strong renewal rates in that area, in contrast to declining demand in other segments of the business, such as one-off event services and remote collaboration post pandemic. 

 

This is a key reason we have partnered with Meta and Lenovo, who are working together as a strategic collective, to sell Meta Quest 3 and 3S headsets into the education and enterprise space, via resellers such as TD Synnex, SHI, Insight, Mace Virtual Labs and others. Since the start of the year, we have secured distribution agreements in preparation for the busy mid-summer to mid-autumn educational buying season.

 

Middle East Growth

Last year, we announced a significant initial agreement with a major client in the Middle East, secured through our partners at PwC. I'm proud to share that, following some delays, we have successfully delivered the project creating a fully immersive learning environment for professional students. Client acceptance was received earlier this month, and we hope to see strong future growth in licenses once results from the first student cohort are available.

 

Education Partners

During 2024, many of our key educational partners not only renewed their agreements with us but a number also expanded their user bases. Two standout partnerships delivered in the year were with Florida-based OptimaED and UK-based InspiredED, both of which have renewed and increased their license commitments.

 

Our partnership with OptimaED has shown significant growth, increasing its licenses sixfold from 500 at the start of 2023 to over 3,000 licenses currently, with plans to double again this year. OptimaED has developed over 200 educational modules on ENGAGE tailored to the United States curriculum. While their primary focus has been the homeschool market, they have begun expanding into traditional brick-and-mortar schools. This summer, ENGAGE and OptimaED are teaming up to offer bundled pricing options for resellers.

 

The AI Effect

Over the past year, one of the most significant trends in the enterprise landscape has been the rapid acceleration of AI adoption, particularly in roles traditionally filled by human workers. This has been especially evident across major tech companies we've historically supported through onboarding and professional development services. As AI becomes more prevalent, the tech industry has experienced widespread layoffs, directly affecting enterprise investment in the XR space.

 

This shift has led to a decreased demand for ENGAGE XR's independent studio development team, which had focused on delivering custom onboarding experiences and enterprise events. In response, we've streamlined the team and implemented a series of cost-saving measures across the organisation. At the same time, we are integrating AI-driven processes to maintain consistent service delivery.

 

While enterprise clients once relied heavily on us for content creation, most of our educational partners now use the platform's built-in tools to develop their own content. This is precisely the goal these tools were designed to support. To scale effectively, it's essential to empower clients to become self-sufficient. We are now reaching a pivotal point in this transition, as we shift our focus toward Annual Recurring Revenue from license sales.

 

AI Integration in the Platform

Last year, we introduced the School of AI within the platform, an initiative that enables students to engage with virtual representations of historical figures and create personalised AI tutors. This feature has been well received and is now being used by thousands of students daily. With the United States government mandating AI education in schools, we see this as a major driver of future sales. We are expanding our AI capabilities in collaboration with Meta, integrating them into our broader reseller offerings.

 

Current trading and outlook

The first five months of the current financial year has seen the Company make good progress in broadening its opportunities but with the company still being impacted by delays in the pipeline converting into signed contracts. As noted above, we have exciting opportunities in the education space, especially in the Middle East but the delivery of revenues from these opportunities still require work, from both the Company and our customers. The delivery of the pipeline will prove crucial to the Company as the Board seeks to meet its expectations for the year. The Board has taken measures to ensure that the Company's cost base is more aligned to the current revenue profile of the Group.

 

Conclusion

2024 was a challenging year for enterprise sales, however we still landed our largest ever deal in the Middle East and renewed contracts with Bank of America, KPMG, and PWC. We continue to work with several US based insurance companies building out onboarding experiences for their clients.

 

The refocus on education and professional training has taken several months and we expect progress in the sales pipeline throughout 2025 and 2026 as we work closely with Meta, Lenovo and a host of global resellers who already have a large potential client base to sell to.

 

 

David Whelan

Chief Executive Officer

3 June 2025

CHIEF FINANCIAL OFFICER'S REVIEW

 

Revenue was down 8% on the prior year from €3.7 million to €3.4 million, driven by a delay in closing some significant contracts in the final quarter of the year which are expected to close in 2025. ENGAGE platform revenue was down 3% on the prior year from €3.3 million to €3.2 million.

 

ENGAGE revenue from education customers was €1.3 million up from €1.1 million in FY23. This was bolstered by significant growth of two long term partners of the company, OptimaED in the USA and InspiredED in the United Kingdom.

 

ENGAGE revenue from Professional Services declined to €0.7 million from €1.1 million driven by a reduction in one off VR events supported by the ENGAGE Event team while ENGAGE revenue from Enterprise customers increased from €1.0 million to €1.2 million, bolstered by the significant education/training related deal signed in partnership with PWC in Saudi Arabia in early 2024.

 

ENGAGE revenue declined in the North American market with 35% of total ENGAGE revenue being generated in North America (2023: 60%). This is due to a shift in focus towards the Middle East where significant opportunities have appeared which the Company is seeking to capitalise on. Revenue from the Middle East was 28% of total ENGAGE revenue (2023: 0%).

 

EBITDA loss was €3.9 million compared to a loss of €4.0 million in the prior year and loss before tax was €4.0 million compared to a loss in 2024 of €4.1 million. This reduced EBITDA loss is primarily driven by reductions in headcount and a disciplined approach to cost control across the Group, offsetting the reduction in revenue in the period.

 

Operating cashflows resulted in a net outflow of €4.3 million for the period. Following recently undertaken cost reductions in Q2 2025, the current run-rate of staff costs and other ongoing costs is expected to be approximately €0.2 million per month for the remainder of 2025 into 2026.

 

At the balance sheet date, trade and other receivables were €1.8 million, ahead of trade and other payables at €0.7 million. Trade receivables represented an average of 57 debtor days (2023: 59 days).

 

The Group's cash position on 31 December 2024 was €3.6 million (2023: €7.9 million) with no debt.

 

Séamus Larrissey

Chief Financial Officer

3 June 2025

CONSOLIDATED STATEMENT OF TOTAL COMPREHENSIVE INCOME

for the Year Ended 31 December 2024

 

 

 

Note

2024

 

2023

Continuing Operations

 

 

 

 

 

 

 

Revenue

3

3,397,251

3,690,697

Cost of Sales

5

(476,728)

(379,640)

Gross Profit

2,920,523

3,311,057

Administrative Expenses

5

(7,104,692)

(7,551,774)

Operating Loss

(4,184,169)

(4,240,717)

 

Finance Income

9

216,122

193,605

Finance Costs

8

(6,449)

(6,966)

Loss before Income Tax

 

(3,974,496)

 

(4,054,078)

 

Income Tax credit

10

-

-

Loss for the financial year

(3,974,496)

(4,054,078)

 

Other comprehensive income

 

 

-

 

-

Total comprehensive loss for the year attributable to owners of the parent

(3,974,496)

(4,054,078)

 

Earnings per Share (EPS) attributable to owners of the parent

Basic earnings per share

Diluted earnings per share

11

11

 

(0.008)

(0.007)

(0.008)

(0.008)

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

at 31 December 2024

 

Note

2024

 

2023

 

 

 

Non-Current Assets

 

 

 

 

Property, Plant & Equipment

12

56,417

123,728

Intangible Assets

13

-

-

56,417

123,728

Current Assets

Trade and other receivables

15

1,786,684

1,195,333

Cash and short-term deposits

16

3,566,927

7,911,079

5,353,611

9,106,412

Total Assets

5,410,028

9,230,140

 

Equity and Liabilities

 

 

 

 

 

 

 

 

 

Equity Attributable to Shareholders

 

 

 

 

Issued share capital

17

524,826

524,826

Share premium

17

43,910,062

43,910,062

Other reserves

18

(12,128,790)

(12,292,523)

Retained earnings

19

(27,589,226)

(23,614,730)

Total Equity

4,716,872

 

8,527,635

Non-Current Liabilities

Lease liabilities

21

-

34,540

 

Current Liabilities

Trade and other payables

22

658,616

615,237

Lease liabilities

21

34,540

52,728

693,156

667,965

Total Liabilities

693,156

 

702,505

Total Equity and Liabilities

5,410,028

 

9,230,140

 

 

COMPANY STATEMENT OF FINANCIAL POSITION

at 31 December 2024

 

 

 

Note

2024

 

2023

 

 

 

Non-Current Assets

 

 

 

 

Investment in subsidiaries

14

3,635,844

12,366,593

3,635,844

12,366,593

Current Assets

Trade and other receivables

15

12,930

25,424

Cash and short-term deposits

16

3,226,157

5,791,641

3,239,087

5,817,065

Total Assets

6,874,931

18,183,658

 

Equity and Liabilities

 

 

 

 

 

 

 

 

 

Equity Attributable to Shareholders

 

 

 

 

Issued share capital

17

524,826

524,826

Share premium

17

43,910,062

43,910,062

Other reserves

18

(1,119,279)

(1,246,172)

Retained earnings

19

(36,503,224)

(25,081,249)

Total Equity

6,812,385

 

18,107,467

Current Liabilities

Trade and other payables

22

62,546

76,191

Total Liabilities

62,546

 

76,191

Total Equity and Liabilities

6,874,931

 

18,183,658

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

for the Year Ended 31 December 2024

 

 

 

 

 

Share

Capital

Share

Premium

Other Reserves

Retained

Earnings

Total

Balance at 1 January 2023

290,451

33,503,300

(11,752,741)

(19,560,652)

2,480,358

 

Total comprehensive income

Other comprehensive income

-

-

-

-

-

Loss for the year

-

-

-

(4,054,078)

(4,054,078)

Total comprehensive income

290,451

33,503,300

(11,752,741)

(23,614,730)

(1,573,720)

 

Transactions with owners

recognised directly in equity

New Shares Issued

234,375

10,406,762

 - 

 - 

10,641,137

Share Issue Costs

 - 

 - 

(601,362)

 - 

(601,362)

Share option expense

 - 

 - 

61,580

 - 

61,580

Balance at 31 December 2023

524,826

43,910,062

(12,292,523)

(23,614,730)

8,527,635

 

 

 

Share

Capital

Share

Premium

Other Reserves

Retained

Earnings

Total

Balance at 1 January 2024

524,826

43,910,062

(12,292,523)

(23,614,730)

8,527,635

 

Total comprehensive income

Other comprehensive income

-

-

-

-

-

Loss for the year

-

-

-

(3,974,496)

(3,974,496)

Total comprehensive income

524,826

43,910,062

(12,292,523)

(27,589,226)

4,553,139

 

Transactions with owners

recognised directly in equity

Share option expense

-

-

163,733

-

163,733

Balance at 31 December 2024

524,826

43,910,062

(12,128,790)

(27,589,226)

4,716,872

 

 

 

COMPANY STATEMENT OF CHANGES IN EQUITY

for the Year Ended 31 December 2024

 

 

 

 

 

Share

Capital

Share

Premium

Other Reserves

Retained

Earnings

Total

Balance at 1 January 2023

290,451

33,503,300

(691,272)

(14,001,259)

19,101,220

 

Total comprehensive income

Other comprehensive income -

-

-

-

-

Loss for the year

 - 

 - 

 - 

(11,079,990)

(11,079,990)

Total comprehensive income

290,451

33,503,300

(691,272)

(25,081,249)

8,021,230

 

Transactions with owners

recognised directly in equity

New Shares Issued

234,375

10,406,762

 - 

 - 

10,641,137

Share Issue Costs

 - 

 - 

(601,362)

 - 

(601,362)

Share option expense

 - 

 - 

46,462

 - 

46,462

Balance at 31 December 2023

524,826

43,910,062

(1,246,172)

(25,081,249)

18,107,467

 

 

 

Share

Capital

Share

Premium

Other Reserves

Retained

Earnings

Total

Balance at 1 January 2024

524,826

43,910,062

(1,246,172)

(25,081,249)

18,107,467

 

Total comprehensive income

Other comprehensive income -

-

-

-

-

Loss for the year

-

-

-

(11,421,975)

(11,421,975)

Total comprehensive income

524,826

43,910,062

(1,246,172)

(36,503,224)

6,685,492

 

Transactions with owners

recognised directly in equity

Share option expense

-

-

126,893

-

126,893

Balance at 31 December 2024

524,826

43,910,062

(1,119,279)

(36,503,224)

6,812,385

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

for the Year Ended 31 December 2024

 

 

 

Note

2024

 

2023

Continuing Operations

 

 

 

 

 

 

 

Loss before income tax

(3,974,496)

(4,054,078)

Adjustments to reconcile loss before tax to net cash flows:

Depreciation of fixed assets

5

91,398

106,179

Amortisation of intangible assets

5

-

39,492

Finance Costs

8

6,449

6,966

Finance Income

9

(216,122)

(193,605)

Share Option Expense

163,733

61,579

Movement in trade & other receivables

(591,351)

170,649

Movement in trade & other payables

43,379

(607,251)

 

(4,477,010)

(4,470,069)

Bank interest received

216,122

193,605

Bank interest & other charges paid

(6,449)

(6,966)

Net Cash used in Operating Activities

(4,267,337)

(4,283,430)

 

 

Cash Flows from Investing Activities

Purchases of property, plant & equipment

12

(24,087)

(17,465)

Net cash used in investing activities

(24,087)

(17,465)

 

Cash Flows from Financing Activities

Proceeds from issuance of ordinary shares

-

10,039,775

Payment of lease liabilities

21

(52,728)

(36,970)

Net cash generated from / (used in) financing activities

(52,728)

10,002,805

 

 

Net increase / (decrease) in cash and cash equivalents

(4,344,152)

5,701,910

Cash and cash equivalents at beginning of year

16

7,911,079

2,209,169

Cash and cash equivalents at end of year

16

3,566,927

7,911,079

 

 

COMPANY STATEMENT OF CASH FLOWS

for the Year Ended 31 December 2024

 

 

 

Note

2024

 

2023

Continuing Operations

 

 

 

 

 

 

 

Loss before income tax

(11,421,975)

(11,079,990)

Adjustments to reconcile loss before tax to net cash flows:

Finance Costs

722

792

Finance Income

(212,386)

(192,971)

Share Option Expense

126,893

46,463

Impairment of Investment in Subsidiaries

10,698,215

10,157,911

Movement in trade & other receivables

12,494

(21,932)

Movement in trade & other payables

(13,645)

(77,354)

 

(809,682)

(1,167,081)

Bank interest received

212,386

192,971

Bank interest & other charges paid

(722)

(792)

Net cash used in Operating Activities

(598,018)

(974,902)

 

 

Cash Flows from Investing Activities

Capital contribution

(1,967,466)

(3,759,402)

Net cash (used) / generated in investing activities

(1,967,466)

(3,759,402)

 

Cash Flows from Financing Activities

Proceeds from issuance of ordinary shares

-

10,039,775

Net cash generated from financing activities

-

 

10,039,775

 

 

Net increase / (decrease) in cash and cash equivalents

(2,565,484)

 

5,305,471

Cash and cash equivalents at beginning of year

16

5,791,641

486,170

Cash and cash equivalents at end of year

16

3,226,157

 

5,791,641

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

 

 

1. General Information

 

ENGAGE XR Holdings plc ("the Company") is publicly traded on the Alternative Investment Market ("AIM") of the London Stock Exchange. The Company is incorporated and domiciled in the Republic of Ireland. The registered office is Unit 9, Cleaboy Business Park, Old Kilmeaden Road, Waterford and the registered number is 613330. The company was previously known as VR Education Holdings plc.

 

The Company is the parent company of ENGAGE XR Limited, previously known as Immersive VR Education Limited. ENGAGE XR Limited is incorporated and domiciled in the Republic of Ireland with the same registered office as the Company.

 

The Company is also the parent company of ENGAGE XR LLC. ENGAGE XR LLC is incorporated and domiciled in USA with a registered office of 251 Little Falls Drive, Wilmington, Delaware, 19808-1674, USA.

 

The Group is principally engaged in the development of the educational Virtual Reality platform ENGAGE. The Company also develops and sells Virtual Reality experiences for the education market.

 

2. Summary of Significant Accounting Policies

 

The principal accounting policies applied in the preparation of the Financial Statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated. The consolidated Financial Statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as adopted by the European Union issued by the International Accounting Standards Board ("IASB") including related interpretations issued by the International Financial Reporting Interpretations Committee ("IFRIC").

 

Basis of Consolidation

The consolidated financial statements incorporate those of ENGAGE XR Holdings plc and its subsidiaries ENGAGE XR Limited and ENGAGE XR LLC.

 

All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

 

Subsidiaries are fully consolidated from the date on which control is transferred to the group. They are deconsolidated from the date on which control ceases. Control is achieved when the group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee.

 

The Group re-assess whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the elements of control.

 

Business Combination

 

Acquisition of ENGAGE XR Limited

The Company entered into an agreement to acquire the entire issued share capital of ENGAGE XR Limited on 12 March 2018. The acquisition was effected by way of issue of shares. Due to the relative size of the companies, ENGAGE XR's shareholders became the majority shareholders in the enlarged capital of the Company. The transaction fell outside of IFRS 3 ("Business Combinations") and as such has been treated as a group reconstruction.

 

Therefore, although the Group reconstruction did not become unconditional until 12 March 2018, these consolidated financial statements are presented as if the Group structure has always been in place, including the activity from incorporation of the Group's subsidiaries.

 

Furthermore, as ENGAGE XR Holdings plc was incorporated on 13 October 2017, while the enlarged group began trading on 12 March 2018, the Statement of Comprehensive Income and consolidated Statement of Changes in Equity and consolidated Cash Flow Statements are presented as though the Group was in existence for the whole year. On this basis, the Directors have decided that it is appropriate to reflect the combination using merger accounting principles as the transaction falls outside the scope of IFRS 3 and as such has been treated as a Group reconstruction. No fair value adjustments have been made as a result of the combination.

 

Significant accounting judgements, estimates and assumptions

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures, and the disclosure of contingent liabilities. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying amount of assets or liabilities affected in future periods.

 

Judgements

In the process of applying the Group's accounting policies, management has made the following judgements, which have the most significant effect on the amounts recognised in the financial statements:

 

Capitalised development costs

In applying the requirements of IAS 38 Intangible Assets, the Group assessed various development projects against the criteria required for capitalisation. Certain projects that did not meet the criteria regarding the ability to determine whether those projects would generate sufficient future economic benefits were expensed. The judgements reflect the early stage of the VR/AR market and will change over time.

 

Estimates and assumptions

The key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are described below. The Group based its assumptions and estimates on parameters available when the financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising that are beyond the control of the Group. Such changes are reflected in the assumptions when they occur.

 

Capitalised development costs impairment review

The Group's impairment review undertaken to assess the carrying value of capitalised development costs includes certain assumptions on future revenues and costs associated with the underlying technology. Those cashflows are discounted at an appropriate discount rate. These estimates and assumptions are reviewed on an on-going basis. Changes in accounting estimates may be necessary if there are changes in the circumstances on which the estimate was based or as a result of new information or more experience. Such changes are recognised in the period in which the estimate is revised.

 

Going Concern

The financial statements have been prepared on a going concern basis which assumes that the group will continue in operational existence for at least one year from the date of approval of these financial statements.

 

At 31 December 2024 the group had a loss for the year of €3,974,496 and at that date net assets amounted to €4,716,872.

 

The group's ability to continue as a going concern is dependent on its ability to trade profitably in the future.

 

In forming this opinion, the Directors have considered all the information available to them. This includes management prepared forecasts, cost saving exercises, finalisation of significant contracts, due consideration of the ability to raise funds on the open market in respect of the listing on the Alternative Investment Market on the London Stock Exchange and the timing as to when such funds will be received.

However, the Directors acknowledge that, in the current climate, assumptions used in financial forecasting are highly dependent on unpredictable future events.

 

Throughout 2025 the Group has continued to work on several significant opportunities in both the Middle East and North America. However, the timing for concluding these deals remains uncertain.

 

As a result of this uncertainty, during May 2025, the Group undertook a restructuring which resulted in a reduction in the size of the team. Together with other costs being eliminated this has resulted in significant savings for the Group. With these cost savings we expect that the Group has sufficient funding for at least 12 months from the date of signing the financial statements and until one or more of the significant opportunities close which will further bolster the cash position of the Group.

 

However, notwithstanding the foregoing, the directors believe that the above circumstances still represent significant challenges and uncertainties which may cast doubt on the company and group's ability to continue as a going concern and therefore it may be unable to realise its assets

and discharge its liabilities in the normal course of business for a period of at least one year from the date of the approval of these financial statements. However, the Board remain optimistic that all actions that have been and continue to be taken will mitigate against these uncertainties.

 

While the directors believe that it is appropriate for the financial statements to be prepared on the going concern basis, the financial statements do not include any adjustments that would result from a situation where the company failed to achieve the projected financial results.

 

Foreign Currency Translation

 

(a) Functional and Presentation Currency

Items included in the Financial Statements of the Group are measured using the currency of the primary economic environment in which the entity operates ("functional currency").

 

The Financial Statements are presented in euro (€), which is the Group's functional and presentation currency.

 

(b) Transactions and Balances

Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions or valuation where items are re-measured. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the income statement, except when deferred in other comprehensive income as qualifying cash flow hedges and qualifying net investment hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the income statement within 'finance income or costs'. All other foreign exchange gains and losses are presented in the income statement within Administrative Expenses.

 

Current versus non-current classification

The Group presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is:

· Expected to be realised or intended to be sold or consumed in the normal operating cycle

· Held primarily for the purpose of trading

· Expected to be realised within twelve months after the reporting period; or

· Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period

 

All other assets are classified as non-current.

 

A liability is current when:

· It is expected to be settled in the normal operating cycle

· It is held primarily for the purpose of trading

· It is due to be settled within twelve months after the reporting period Or

· There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period

 

The Group classifies all other liabilities as non-current.

Segment Reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Board of Directors that makes strategic decisions.

 

Fair value measurement

The Group measures financial instruments such as derivatives at fair value at each balance sheet date. The Company has applied IFRS 9 for all periods presented.

 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

 

· In the principal market for the asset or liability; or

· In the absence of a principal market, in the most advantageous market for the asset or liability

 

The principal or the most advantageous market must be accessible by the Group. The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.

 

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximising the use of relevant observable inputs and minimising the use of unobservable inputs.

 

Revenue Recognition

Revenue is measured at the fair value of the consideration received or receivable, and represents amounts receivable for goods and services supplied, stated net of discounts, returns and Value-Added Taxes (VAT).

 

Under IFRS 15, Revenue from Contracts with Customers, five key points to recognise revenue have been assessed:

Step 1: Identify the contract(s) with a customer;

Step 2: Identify the performance obligations in the contract;

Step 3: Determine the transaction price;

Step 4: Allocate the transaction price to the performance obligations in the contract; and

Step 5: Recognise revenue when (or as) the entity satisfies a performance obligation.

 

The Group recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity, and specific criteria have been met for each of the Group's activities, as described below. The Group bases its estimates on historical results, taking into consideration the type of customer, the type of transaction and the specifics of each arrangement.

Where the Group makes sales relating to a future financial period, these are deferred and recognised under 'deferred revenue' on the Statement of Financial Position. The Group currently has two revenue streams:

 

ENGAGE Revenue

The Group is primarily focused on developing a proprietary VR platform which is sold through licences and professional services revenue. This is considered "ENGAGE Revenue" for reporting purposes. Revenue is recognised when the license is delivered to the customer, or when all performance obligations have been achieved.

 

Showcase Experiences

The Group also develops proprietary educational VR content which is sold through licences. This is considered "Showcase Experience Revenue" for reporting purposes. Revenue is recognised when the license key is delivered to the customer, or when all performance obligations have been achieved.

 

Revenue is received net of commission from the platforms where the Group licenses their content. The gross amount of revenue is recognised in revenue with the corresponding commission portion recognised in cost of sales.

 

Other Revenue

The Group develops educational VR content on behalf of customers based on specific customer requirements. This is considered "Other Revenue" for reporting purposes. Such revenue is recognised on a percentage completion basis unless there are significant performance obligations that would require deferral until such obligations are delivered. Stage of completion is measured by reference to labour hours incurred to date as a percentage of total estimated labour hours for each contract. When the contract outcome cannot be measured reliably, revenue is recognised only to the extent that the expenses incurred are eligible to be recovered. This is generally during the early stages of development where the specifications need to pass through the customer's approval as part of the development.

 

The disaggregation of revenue, required under IFRS 15, has been prepared on the basis of the two revenue streams outlined above and is included in Note 3.

 

Government Grants

Government grants are recognised where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognised as income on a systematic basis over the periods that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, it is recognised as income in equal amounts over the expected useful life of the related asset.

 

Property, Plant and Equipment

All property, plant and equipment is stated at historical cost less depreciation. Historical cost includes expenditure that is directly attributable to the acquisition of the items. Cost may also include transfers from equity of any gains/losses on qualifying cash flow hedges of foreign currency purchases of property, plant and equipment.

 

Subsequent costs are included in the asset's carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognised. All other repairs and maintenance are charged to the income statement during the financial period in which they are incurred.

 

Depreciation on assets is calculated using the straight-line method to allocate their cost less residual value over their estimated useful lives, as follows:

 

Office equipment - 3 - 5 years

Furniture, fittings and equipment - 5 years

Leasehold improvements - over the life of the leased asset

 

Right-of-use assets are depreciated over the shorter of the asset's useful life and the lease term on a straight line basis.

 

The assets' residual values and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount, and are recognised in the income statement.

 

Intangible Assets

Research costs are expensed as they are incurred. Development costs that are directly attributable to the design and testing of identifiable and unique commercial software controlled by the Group are recognised as intangible assets when the following criteria are met:

 

· it is technically feasible to complete the software product so that it will be available for use and sale;

· management intends to complete the software product and use or sell it;

· there is an ability to use or sell the software product;

· it can be demonstrated how the software product will generate future economic benefits;

· adequate technical, financial and other resources to complete the development and use or sell the software product are available; and

· the expenditure attributable to the software product during its development can be reliably measured.

 

Directly attributable costs that are capitalised as part of the software product include the software development employee costs and subcontracted development costs.

 

Other development expenditure that does not meet these criteria is recognised as an expense as incurred. Development costs previously recognised as an expense are not recognised as an asset in a subsequent period.

 

Computer software development costs recognised as assets are amortised over their estimated useful lives, which do not exceed 3 years and commences after the development is complete and the asset is available for use. Intangible assets in relation to Showcase Experiences are amortised over their estimated useful lives based on the pattern of consumption of the underlying economic benefits. The ENGAGE platform is amortised on a straight line basis over 3 years. Amortisation is included in Administrative Expenses.

The Group assesses, at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Group estimates the asset's recoverable amount. An asset's recoverable amount is the higher of an asset's or CGU's fair value less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets.

 

When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.

 

The Group bases its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Group's CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years. A long-term growth rate is calculated and applied to project future cash flows after the fifth year.

 

Impairment losses of continuing operations are recognised in the statement of profit or loss in expense categories consistent with the function of the impaired asset.

 

For assets, an assessment is made at each reporting date to determine whether there is an indication that previously recognised impairment losses no longer exist or have decreased. If such indication exists, the Group estimates the asset's or CGU's recoverable amount.

 

A previously recognised impairment loss is reversed only if there has been a change in the assumptions used to determine the asset's recoverable amount since the last impairment loss was recognised. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognised for the asset in prior years.

 

Trade Receivables

Trade receivables are amounts due from customers for licenses sold or services performed in the ordinary course of business. If collection is expected in one year or less (or in the normal operating cycle of the business if longer), they are classified as current assets. If not they are presented as non-current assets.

 

Trade receivables are recognised initially at fair value, and subsequently measured at amortised cost using the effective interest method, less provision for impairment. The Group holds the trade receivables with the objective of collecting the contractual cash flows.

 

The Group provides for known bad debts and other accounts over a certain age in line with Group policy. The realisation of the asset may differ from the provision estimated by management.

 

Cash and Cash Equivalents

In the Statement of Cash Flows, cash and cash equivalents comprise cash in hand and short-term deposits. Bank overdrafts are shown within borrowings in current liabilities on the Statement of Financial Position.

 

Capital Contributions

A capital contribution represents irrevocable, non-repayable amounts contributed from connected parties. Capital contributions are accounted for as a contribution when they are approved, through the profit and loss account reserve.

Share Capital

Ordinary shares are classified as equity.

 

Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds. Where the issuance of the new shares or options occurs in a subsequent period from when the incremental costs are incurred these costs are prepaid until the issuance takes place.

 

Share Based Payments

The Group has an equity settled employee incentive plan. The cost of equity settled transactions with employees is measured by reference to the fair value at the date at which they are granted and is recognised as an expense over the vesting period, which ends on the date on which the relevant employees become fully entitled to the award. Fair value is determined using an appropriate pricing model. In valuing equity-settled transactions, no account is taken of any vesting conditions, other than conditions linked to the price of the shares of the Group. No expense is recognised for awards that do not ultimately vest.

 

At each reporting date before vesting, the cumulative expense is calculated, representing the extent to which the vesting period has expired and management's best estimate of the achievement or otherwise of non-market conditions number of equity instruments that will ultimately vest. The movement in cumulative expense since the previous reporting date is recognised in the profit and loss within administration expenses, with a corresponding entry in the balance sheet in share options reserve.

 

Where the terms of an equity-settled award are modified or a new award is designated as replacing a cancelled or settled award, the cost based on the original award terms continues to be recognised over the original vesting period. In addition, an expense is recognised over the remainder of the new vesting period for the incremental fair value of any modification, based on the difference between the fair value of the original award and the fair value of the modified award, both as measured on the date of the modification. No reduction is recognised if this difference is negative. Where an equity-settled award is cancelled, it is treated as if it had vested on the date of cancellation, and any cost not yet recognised in the Statement of Comprehensive Income for the award is expensed immediately.

 

Trade Payables

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities. Trade payables are recognised initially at fair value, and subsequently measured at amortised cost using the effective interest method.

 

Leases

The Group leases office premises and motor vehicles under rental contracts for fixed periods but may contain extension options. Lease terms are negotiated on an individual basis and contain different terms and conditions. The lease agreements entered into by the Group do not impose any covenants other than the security interests in the leased assets that are held by the lessor.

 

From 1 January 2019 leases are recognised as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the Group. Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments:

· Fixed payments less any lease incentives receivable;

· Variable lease payments that are based on an index or a rate;

· The exercise price of a purchase option if the Group is reasonably certain to exercise that option; and

· Payments of penalties for terminating the lease.

Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability.

 

 

The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined the lessee's incremental borrowing rate is used. Lease payments are allocated between principal and finance cost. The finance charge is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability.

 

Payments associated with short-term leases (12 months or less) and leases of low-value assets are recognised on a straight-line basis as an expense in profit or loss.

 

Current and Deferred Income Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the income statement, except to the extent that it relates to items recognised directly in equity. In this case the tax is also recognised directly in other comprehensive income or directly in equity, respectively.

 

The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period in the countries where the Group operates and generates taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions where appropriate on the basis of amounts expected to be paid to the tax authorities.

 

Deferred income tax is recognised, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the Financial Statements. However, the deferred tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that, at the time of the transaction, affects neither accounting nor taxable profit or loss. Deferred income tax is determined using tax rates (and laws) that have been enacted, or substantially enacted, by the end of the reporting period and are expected to apply when the related deferred income tax asset is realised, or the deferred income tax liability is settled.

 

Deferred income tax assets are recognised only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised. Deferred income tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets against current tax liabilities, and when the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.

 

Research and development tax credit

The Group undertakes certain research and development activities that qualify for the receipt of a research and development (R&D) tax credit from the Irish tax authorities. Such grants are recognised as a credit against related costs on a cash receipts basis.

Financial Instruments

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

Financial Assets

Initial Recognition and Measurement

In accordance with IFRS9, 'Financial Instruments' the Group has classified its financial assets as 'Financial assets at amortised cost'. The Group determines the classification of its financial assets at initial recognition. All financial assets are recognised initially at fair value plus, in the case of assets not at fair value through the Statement of Comprehensive Income, transaction costs that are attributable to the acquisition of the financial asset and expected credit losses based on historical collection experience of similar assets.

 

Subsequent Measurement

The subsequent measurement of financial assets depends on their classification as described below:

 

Financial Assets Carried at Amortised Cost

This category applies to trade and other receivables due from customers in the normal course of business. All amounts which are not interest bearing are stated at their recoverable amount, being invoice value less provision for any expected credit losses. These assets are held at amortised cost. The group classifies its financial assets as at amortised cost only if both of the following criteria are met:

I. the asset is held within a business model with the objective of collecting the contractual cash flows; and

II. the contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal outstanding.

 

Financial assets at amortised cost comprise current trade and other receivables due from customers in the normal course of business and cash and cash equivalents. The Group does not hold any material financial assets at fair value through other comprehensive income or at fair value through the Statement of Comprehensive Income. The Group does not hold any derivatives and does not undertake any hedging activities.

 

Trade receivables are initially recognised at their transaction price. The group does not expect to have any contracts where the period between the transfer of the promised goods or services to the customer and payment by the customer exceeds one year. As a consequence, the group does not adjust any of the transaction prices for the time value of money. Other financial assets are recognised initially at fair value plus transaction costs that are directly attributable to the acquisition of the financial asset. Trade and other receivables are subsequently measured at amortised cost less provision for expected credit losses.

 

Impairment of Financial Assets

The Group assesses on a forward looking basis the expected credit losses associated with its financial assets measured at amortised cost. The Group applies the simplified approach to providing for expected credit losses prescribed by IFRS 9, which permits the use of the lifetime expected loss provision for all trade receivables. To measure the expected credit losses, trade receivables have been grouped based on shared credit risk characteristics and the days past due. For other financial assets at amortised cost, the Group determines whether there has been a significant increase in credit risk since initial recognition. The Group recognises twelve month expected credit losses if there has not been a significant increase in credit risk and lifetime expected credit losses if there has been a significant increase in credit risk.

 

Expected credit losses incorporate forward looking information, take into account the time value of money when there is a significant financing component and are based on days past due; the external credit ratings of its customers; and significant changes in the expected performance and behaviour of the borrower.

 

Financial assets are written off when there is no reasonable expectation of recovery. Where receivables have been written off, the Group continues to engage in enforcement activity to attempt to recover the receivable due. Where recoveries are made, these are recognised in the Statement of Comprehensive Income.

 

Financial Liabilities

 

Initial Recognition and Measurement

All financial liabilities are recognised initially at fair value net of directly attributable transaction costs.

 

The Group's financial liabilities include trade and other payables.

 

After initial recognition, interest bearing loans and borrowings are subsequently measured at amortised cost using the effective interest rate method (EIR). Gains and losses are recognised in the Statement of Comprehensive Income when the liabilities are derecognised as well as through the (EIR) amortisation process.

 

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included in finance costs in the Statement of Comprehensive Income. This category generally applies to interest-bearing loans and borrowings.

 

Derecognition of Financial Assets and Liabilities

A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is derecognised when: (1) The rights to receive cash flows from the asset have expired, or (2) The Group has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a 'pass-through' arrangement, and either (a) the Group has transferred substantially all the risks and rewards of the asset, or (b) the Group has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the assets.

A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognised in the Statement of Comprehensive Income.

 

New Standards, amendments, and interpretations not adopted by the group

The group did not adopt any new standards, amendments or interpretations in year as they did not have a material impact on the financial statements.

 

New standards, amendments, and interpretations issued but not effective for the period ended 31 December 2024, and not early adopted

There are several amendments to IFRS Accounting Standards that became applicable from 1 January 2024:

 

- Classification of Liabilities as Current or Non-current and Non-current liabilities with covenants - Amendments to IAS1;

- Lease Liability in a Sale and Leaseback - Amendments to IFRS 16;

- Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7.

 

None of these is expected to have a significant effect on the financial statements of the Group or Parent Company.

 

3. Segment Reporting

 

 

2024

 

2023

Revenue by Type

 

 

 

 

 

ENGAGE revenue

 

 

Education License Revenue

1,256,165

 

 1,165,294

Enterprise License Revenue

1,202,819

 

 1,007,204

Professional Services Revenue

735,228

 

 1,133,483

Total ENGAGE Revenue

3,194,212

 

3,305,981

 

Showcase experience revenue

203,039

324,924

Other revenue

-

59,792

Total Revenue

3,397,251

3,690,697

 

 

Education License Revenue is comprised of license revenue derived from customers with an education focus.

 

Enterprise License Revenue is comprised of licence revenue derived from customers with an enterprise focus.

 

Professional Services Revenue includes revenue from custom development work performed by the ENGAGE Studio team and also revenue generated from one off VR events.

 

Showcase Experience Revenue includes revenue from the sale of our showcase experiences including Apollo 11 VR, Titanic VR and Shuttle Commander on the Oculus, Steam and PlayStation Stores.

 

Other Revenue includes revenue from VR installations within museums.

 

Total revenue recognised in the reporting period from performance obligations satisfied (or partially satisfied) in previous periods was €432,029 (2023: €446,103)

 

4. Capital Management

 

For the purpose of the Company's capital management, capital includes issued capital, share premium and all other equity reserves. The primary objective of the Group's capital management is to maximise the shareholder value.

 

Group

2024

 

2023

 

 

 

 

 

 

Lease liabilities

(34,540)

(87,268)

Trade and other payables

(658,616)

(615,237)

Less: cash and short-term deposits

3,566,927

7,911,079

Net Funds

2,873,771

7,208,574

Equity

4,716,872

8,527,635

Total Equity

4,716,872

8,527,635

Capital and net funds

7,590,643

15,736,209

 

 

5. a. Expenses by nature

2024

 

2023

 

Depreciation charges

91,398

106,179

Amortisation expense

 - 

39,492

Operating Lease Payments

15,926

26,848

Foreign Exchange Loss / (Gain)

(153,556)

103,229

Staff Costs

5,066,103

5,272,155

Contractor Costs

1,128,931

1,250,703

Research & Development Tax Credit Received

 - 

(435,954)

Other Expenses

 1,432,618

1,568,762

Total cost of sales and administrative expenses

7,581,420

7,931,414

 

Disclosed as:

Cost of sales

476,728

379,640

Administrative expenses

7,104,692

 

7,551,774

Total cost of sales and administrative expenses

7,581,420

7,931,414

 

The aggregate amount of research and development expenditure recognised as an expense within cost of sales and administrative expenses was €2,041,049 (2023: €1,583,220)

 

 

b. Auditor Remuneration

 

Services provided by the Company's auditor

During the year, the Company obtained the following services from the Company's auditor:

 

2024

 

2023

 

Fees payable to the Company's auditor for the audit of the financial statements

 

 

53,000

 

51,000

 

6. Employees

 

Employee Benefit Expense

2024

 

2023

 

Wages and salaries

4,425,136

4,690,144

Social security costs

409,515

458,064

Defined contribution pension costs

67,719

62,368

Share option expense

163,733

61,579

Total Employee Benefit Expense

5,066,103

5,272,155

 

Average Number of People Employed

 

2024

 

 

2023

 

 

 

Average number of people (including executive Directors)

employed:

Operations

48

53

Administration

4

4

Sales, Marketing and Customer Support

6

10

Total Average Headcount

58

67

 

 

7. Directors remuneration

 

Below is the Directors' remuneration for the Year Ended 31 December 2024 and for the year ended 31 December 2023

 

 

 

31 December 2024

 

Group

Salaries and fees

Pension benefits

Options / Warrants issued

Total

Executive Directors

David Whelan

 215,250

 4,641

 52,038

 271,929

Sandra Whelan

 167,750

 4,594

 52,038

 224,382

Séamus Larrissey

 

Non-executive Directors

 162,250

 6,563

 12,809

 181,622

Richard Cooper

 97,711

-

-

 97,711

Kenny Jacobs

 28,500

-

-

 28,500

Karthik Manimozhi

 83,868

-

10,007

 93,875

Marc Metis

-

-

-

-

 755,329

 15,798

 126,892

 898,019

 

 

 

 

31 December 2023

 

Group

Salaries and fees

Pension benefits

Options / Warrants issued

Total

Executive Directors

David Whelan

 235,875

 6,445

 20,686

 263,006

Sandra Whelan

 183,792

 5,870

 20,686

 210,348

Séamus Larrissey

 

Non-executive Directors

 157,750

 6,380

 5,092

 169,222

Richard Cooper

90,981

-

-

90,981

Praveen Gupta

-

-

-

-

Kenny Jacobs

29,688

-

-

29,688

698,086

18,695

46,464

763,245

 

 

The options issued are a non-cash amount and are accounted for in line with the treatment of the other share options issued to employees under IFRS 2. Further notes on Share Based Payments are included in Note 20.

 

 

8. Finance Costs

 

2024

 

2023

 

Interest expense:

- Lease interest

3,950

4,305

- Bank charges

2,499

2,661

Total finance costs

6,449

6,966

 

 

9. Finance Income

 

2024

 

2023

 

Bank Interest Received

216,122

193,605

Total finance income

216,122

193,605

 

 

10. Income Tax

 

2024

 

2023

 

Current tax:

Current tax on loss for the year

-

-

Total current tax

-

-

Deferred tax (Note 23)

-

 

-

Income Tax

-

 

-

 

The tax assessed for the year differs from that calculated using the standard rate of corporation tax in Ireland (12.5%). The differences are explained below:

 

 

2024

 

2023

 

Loss Before Tax

(3,974,496)

 

(4,054,078)

 

 

 

Tax calculated at domestic tax rates applicable to loss in

Ireland of 12.5%

 

 

(496,812)

 

 

(506,760)

Tax effects of:

- Depreciation in excess of capital allowances

5,595

7,166

- Expenses not deductible for tax purposes

65,779

(52,917)

- Tax losses for which no deferred tax asset was recognised

425,438

552,511

Total tax

-

-

 

 

11. Earnings per share (EPS)

 

2024

 

2023

Loss attributable to equity holders of the Group:

 

Continuing Operations

(3,974,496)

(4,054,078)

Weighted average number of shares for Basic EPS

524,826,146

484,149,493

Effects of dilution from share options and warrants

43,241,898

19,404,283

Weighted average number of ordinary shares adjusted for the effect of dilution

568,068,044

503,553,776

Basic loss per share from continuing operations

(0.008)

(0.008)

Diluted loss per share from continuing operations

(0.007)

(0.008)

 

12. Property, Plant & Equipment

 

 

 

Group

 

Leasehold

improvements

Fixtures,

fittings and equipment

 

Office

Equipment

 

Right of use

assets

 

 

Total

Cost of Valuation

At 1 January 2023

20,341

7,025

369,040

156,031

552,437

Additions

-

-

 17,465

 116,357

 133,822

Disposals

-

-

-

(145,702)

(145,702)

At 31 December 2023

20,341

7,025

 386,505

 126,686

 540,557

Additions

-

-

24,087

-

24,087

At 31 December 2024

 20,341

 7,025

 410,592

 126,686

 564,644

 

Depreciation

At 1 January 2023

 20,341

 7,025

 280,838

 148,148

 456,352

Charge (note 5)

-

 -

 69,207

 36,972

 106,179

Disposals

-

-

-

(145,702)

(145,702)

At 31 December 2023

 20,341

7,025

350,045

39,418

416,829

Charge (note 5)

-

-

 38,670

 52,728

 91,398

At 31 December 2024

 20,341

 7,025

 388,715

 92,146

 508,227

 

Net Book Amount

At 31 December 2023

-

-

36,460

87,268

123,728

At 31 December 2024

 -

 -

 21,877

 34,540

 56,417

 

Depreciation expense of €91,398 (2023: €106,179) has been charged in 'Administrative Expenses'.

Right of use asset relates to properties and vehicles held under lease.

 

13. Intangible Assets

 

 

 

Group

Software in development costs

 

 

 

Total

 

Cost

At 31 December 2023 and 31 December 2024

2,136,231

2,136,231

 

Amortisation

At 31 December 2023 and 31 December 2024

2,136,231

2,136,231

 

Net Book Value

 

At 31 December 2023 and 31 December 2024

-

-

 

 

The software being developed relates to the creation of virtual reality experiences and an online virtual learning and corporate training platform.

 

ENGAGE is an online virtual learning and corporate training platform currently in development by the Company. A desktop version was released in December 2018 and the mobile version was released in December 2019. Amortisation commenced when the mobile version launched.

 

Titanic VR which is available for sale across all major VR capable platforms since November 2018 has commenced being amortised in the period. Raid on the Ruhr launched during 2019 and amortisation commenced during the period. Space Shuttle launched during 2020 and amortisation commenced during the period.

 

An impairment review was carried out at the balance sheet date. No impairment arose.

 

14. Investments in Subsidiaries

 

 

 

 

Company

 

 

At 1 January 2023

18,765,102

Capital contributions

3,759,402

Impairment Adjustment

(10,157,911)

At 31 December 2023

12,366,593

Capital contributions

 

 

1,967,466

Impairment Adjustment

 

 

(10,698,215)

At 31 December 2024

 

 

3,635,844

 

Investments in subsidiaries are recorded at cost, which is the fair value of the consideration paid.

 

On 12 March 2018, the Company acquired all of the issued capital of ENGAGE XR Limited for a consideration of €15,000,000 which was settled by issuing 133,089,739 Ordinary Shares in the Company. The Company incurred expenses totalling €28,809 as part of the transaction.

 

On 31 December 2021 the Company resolved to enter into a capital contribution agreement with ENGAGE XR Limited to facilitate the funding of the wholly owned subsidiary. An amount of €1,967,466 was forwarded (2023: €3,759,402) to ENGAGE XR Limited to the Company during 2024. A repayment arises if ENGAGE XR Limited holds excess funds in a particular currency that is required by ENGAGE XR Holdings PLC to meet its liabilities as they fall due.

 

On 14 July 2022 the Company acquired all of the issued share capital of ENGAGE XR LLC for a consideration of $100,000.

 

The Board have recognised an impairment adjustment of €10,698,215 (2023: €10,157,911) in the current year to reflect the market capitalisation of the group at 31 December 2024.

 

 

 

Name

Country of incorporation and residence

 

 

Nature of business

Proportion of equity shares held by the company

 

ENGAGE XR Limited

 

Ireland

Virtual Reality Technology

 

100%

 

ENGAGE XR LLC

 

USA

Virtual Reality Technology

 

100%

 

This subsidiary undertakings are included in the consolidation. The proportion of the voting rights in the subsidiary undertakings held directly by the Parent Company does not differ from the proportion of ordinary shares held. 

 

15. Trade and Other Receivables

 

Current

Group

 

Company

 

2024

2023

 

2024

2023

 

 

Trade receivables

531,100

591,665

-

-

Less: provision for impairment of receivables

-

-

-

-

Trade receivables - net

531,100

591,665

-

-

Prepayments

197,089

156,820

12,494

24,603

Accrued income

1,045,282

432,029

 - 

-

Other debtors

937

3,100

 - 

-

VAT

12,276

11,719

436

821

1,786,684

1,195,333

12,930

25,424

As at 31 December 2024, trade receivables of €531,100 (2023: €591,665) were fully performing and deemed fully recoverable. No bad debt provision charge was incurred during 2024 (2023: €Nil).

 

The Group assesses exposure to credit risk arising from outstanding receivables on an annual basis. The maximum exposure to credit risk at the reporting date is the carrying value of each of the receivables above. The Group does not consider the credit risk of any receivable has increased post recognition.

 

The Group does not expect any losses from outstanding receivables in the current year.

 

The carrying amounts of the Company's trade and other receivables are denominated in the following currencies:

 

Group

 

Company

 

2024

2023

 

2024

2023

 

 

Euro - Neither past due nor impaired

110,205

186,075

-

-

Pound Sterling - Neither past due nor impaired

41,793

-

-

-

Dollar - Neither past due nor impaired

379,102

405,590

-

-

531,100

591,665

-

-

 

 

16. Cash and short-term deposits

 

 

Group

 

Company

 

2024

2023

 

2024

2023

 

 

Cash at bank and on hand

3,566,927

7,911,079

3,226,157

5,791,641

3,566,927

7,911,079

3,226,157

5,791,641

 

 

17. Issued Share Capital and Premium

 

 

 

Number of shares

Ordinary shares

Share premium

Total

 

 

 

 

 

At 1 January 2024 and at 31 December 2024

524,826,146

524,826

43,910,062

44,434,888

 

 

As at 31 December 2024 the number of shares authorised for issue were 524,826,146 (2023: 524,826,146). The par value of the shares authorised for issue were €0.001 each (2023: €0.001 each).

 

 

18. Other Reserves

 

 

Group

 

Company

 

 

At 1 January 2023

(11,752,741)

(691,272)

Share issue costs

(601,362)

(601,362)

Share option expense

61,580

46,462

At 31 December 2023

(12,292,523)

(1,246,172)

 

At 1 January 2024

(12,292,523)

(1,246,172)

Share option expense

163,733

126,893

At 31 December 2024

12,128,790

1,119,279

 

 

19. Retained Earnings

 

 

Group

 

Company

 

 

At 1 January 2023

(19,560,652)

(14,001,259)

Loss for the year

(4,054,078)

(11,079,990)

At 31 December 2023

(23,614,730)

(25,081,249)

 

At 1 January 2024

(23,614,730)

(25,081,249)

Loss for the year

(3,974,496)

(11,421,975)

At 31 December 2024

(27,589,226)

(36,503,224)

 

Capital contributions represent irrevocable, non-repayable amounts contributed from connected parties.

 

 

20. Share Based Payments

 

Following the successful completion of the equity placing in 2023, the Remuneration Committee evaluated appropriate solutions to put in place suitable longer-term incentives aimed at aligning the interests of employees and shareholders. The option grant was also to assist with the retention and motivation of key employees of the Company as the Company looks to deliver against the strategic opportunity outlined at the time of the placing. The Options provided the potential for rewards only if shareholders benefit from sustained growth in shareholder value over the coming years.

 

New Scheme

 

Under this new option grant there were 2,700,000 (2023: 38,493,393) employee options granted during 2024 at an exercise price of €0.046 per share.

 

The Options were granted at a price of GBP£0.04 each (€0.046) and cannot be exercised for at least three years from the date of grant (other than on a change of control).

 

The Options have performance criteria linked to the future share price performance of the Company with:

 

- One third of the Options being capable of exercise if the five day volume-weighted average price preceding the date of such exercise was 12 pence or higher; and

 

- One third of the Options being capable of exercise if the five day volume-weighted average price preceding the date of such exercise was 16 pence or higher; and

 

- One third of the Options being capable of exercise if the five day volume-weighted average price preceding the date of such exercise was 20 pence or higher.

 

The Options will vest in full on a change of control provided a minimum price threshold of 10 pence per share is met. Options expire at the end of a period of 7 years from the Grant Date or on the date on which the option holder ceases to be an employee.

 

The movement in employee share options under the new option grant and weighted average exercise prices are as follows for the reporting periods presented:

2024

2023

At 1 January

38,493,393

-

Granted during period

 2,700,000

 38,493,393

Exercised during period

-

-

Forfeited during period

(290,000)

-

At 31 December

40,903,393

38,493,393

Options outstanding at 31 December

Number of shares

40,903,393

38,493,393

Weighted average remaining contractual life

5.65

6.59

Weighted average exercise price per share

€0.046

€0.046

Range of exercise price

€0.046

€0.046

Exercisable at 31 December

Number of shares

-

-

Weighted average exercise price per share

-

-

 

 

 

The Company has measured the fair value of the services received as consideration for equity instruments of the Company, indirectly by reference to the fair value of the equity instruments. The table below sets out the options and warrants that were issued during the period and the principal assumptions used in the Monte Carlo valuation model.

 

Employee

Non-Executive

Director

Number of options

200,000

2,500,000

Grant date

1 January

1 July

Vesting period

3 years

3 years

Share price at date of grant

€0.024

€0.015

Exercise price

€0.046

€0.046

Option life

7 years

7 years

Dividend yield

0%

0%

Staff Retention Rate

90%

90%

Risk free investment rate

4.47%

4.47%

Fair value per option at grant date

€0.0235

€0.0235

Weighted average remaining contractual life in years

6.01

 

6.50

 

The expected life is based on historical data and current expectations and is not necessarily indicative of exercise patterns that may occur. The expected volatility reflects the assumptions that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.

 

Old Scheme

 

No new options were granted in 2024 under the old scheme (2023: Nil).

 

The existing options from the old scheme vest subject to continued service by the employee over a period of 3 years. Options expire at the end of a period of 7 years from the Grant Date or on the date on which the option holder ceases to be an employee.

 

The Company has measured the fair value of the services received as consideration for equity instruments of the Company, indirectly by reference to the fair value of the equity instruments using the Black Scholes valuation model. 

 

The movement in employee share options and weighted average exercise prices are as follows for the reporting periods presented:

 

2024

2023

At 1 January

3,585,080

 4,404,127

Granted during period

 -

 -

Exercised during period

-

-

Forfeited during period

-

(819,047)

At 31 December

3,585,080

3,585,080

Options outstanding at 31 December

Number of shares

3,585,080

3,585,080

Weighted average remaining contractual life

0.35

1.63

Weighted average exercise price per share

€0.022

€0.022

Range of exercise price

€0.0001 - €0.135

€0.0001 - €0.135

Exercisable at 31 December

Number of shares

3,585,080

3,585,080

Weighted average exercise price per share

€0.022

€0.022

 

The total expense recognised in respect of all employee share-based payments and credited to the share-based payment reserve in equity was €163,733 (2023: €61,579).

 

21. Leases

 

Amounts recognised in the Statement Of Financial Position

 

The Statement Of Financial Position shows the following amounts relating to leases:

 

 

Group

 

Company

Right of Use Assets

2024

2023

 

2024

2023

 

 

Buildings

20,913

62,741

-

-

Vehicles

13,627

24,527

-

-

34,540

87,268

-

-

 

 

Group

 

Company

Lease Liabilities

2024

2023

 

2024

2023

 

 

Current

34,540

52,728

-

-

Non-current

-

34,540

-

-

34,540

87,268

-

-

 

 

Amounts recognised in the Consolidated Statement Of Total Comprehensive Income

 

The Consolidated Statement Of Total Comprehensive Income shows the following amounts relating to leases:

 

Depreciation charge of right-of-use assets

2024

 

2023

 

 

 

 

Buildings

41,828

20,914

Vehicles

10,900

16,058

 

52,728

36,972

 

 

Interest expense (included in finance cost)

3,950

4,305

 

22. Trade and Other Payables

 

 

 

Group

 

Company

 

2024

2023

 

2024

2023

 

 

Trade Payables

107,454

113,622

6,960

5,107

Amounts Due to Related Parties

 - 

-

 - 

-

PAYE/PRSI

106,700

133,622

12,482

25,850

VAT

 - 

-

 - 

-

Deferred Income

152,060

115,902

 - 

-

Accrued Expenses

292,402

252,091

43,104

45,234

658,616

615,237

62,546

76,191

 

Terms and conditions of the above financial liabilities:

· Trade payables are non-interest bearing and are normally settled on 30-day terms

· Amounts Due to Related Parties are non-interest bearing and are settled over varying terms throughout the year

· PAYE/PRSI payables are non-interest bearing and are normally settled on 30-day terms

· VAT payables are non-interest bearing and are normally settled on 60-day terms

· Deferred income is non-interest bearing and are settled over varying terms throughout the year

· Accrued expenses are non-interest bearing are settled over varying terms throughout the year

 

 

23. Deferred Tax

 

Deferred income tax assets are recognised for tax loss carry-forwards to the extent that the realisation of the related tax benefit through future taxable profits is probable. The Company did not recognise deferred income tax assets of €2,924,257 (2023: €2,525,356) in respect of losses and depreciation in excess of capital allowances amounting to €23,394,055 (2023: €20,202,845) that can be carried forward against future taxable income.

 

24. Related Parties

 

During the year the Directors received the following emoluments:

 

 

Group

 

Company

 

2024

2023

 

2024

2023

Directors

 

 

Aggregate emoluments

771,127

716,781

771,127

716,781

Share option expense

126,893

46,463

126,893

46,463

 

898,020

763,244

898,020

763,244

 

Included in the above is an amount of €97,711 (2023: €90,981) paid to Luclem Estates and Advisory Limited, a company in which Richard Cooper, a director of the Company, is also a director. These fees relate to Richard Cooper's consultancy services to the Company. As at 31 December 2024 €Nil was outstanding.

 

25. Capital Management

 

The capital of the company is managed as part of the capital of the group as a whole. Full details, are contained in note 4 to the consolidated financial statements.

 

26. Events after the reporting date

 

The Company has evaluated all events and transactions that occurred after 31 December 2024 up to the date of signing of the financial statements.

No material subsequent events have occurred that would require adjustment to or disclosure in the financial statements.

 

27. Contingent Liabilities

 

The company has indicated that it will guarantee the liabilities (as defined in Section 397 of the

Companies Act 2014) of €590,915 (2023: €681,023) its Irish subsidiary, ENGAGE XR Limited for the Year Ended 31 December 2024.

 

28. Ultimate controlling party

 

The Directors believe that there is no ultimate controlling party as no one shareholder has control of the Company.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UUUVRVNUNRAR

Related Shares:

Engage Xr
FTSE 100 Latest
Value8,846.88
Change12.85